Follow
Robert Hoepner
Robert Hoepner
Dept. Neurology Inselspital Bern, Switzerland
Verified email at insel.ch
Title
Cited by
Cited by
Year
Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients
S Dahlhaus, R Hoepner, A Chan, I Kleiter, O Adams, C Lukas, K Hellwig, ...
J Neurol Neurosurg Psychiatry 84 (10), 1068-1074, 2013
1132013
Cerebrospinal fluid JC virus antibody index for diagnosis of natalizumab‐associated progressive multifocal leukoencephalopathy
C Warnke, G Geldern, P Markwerth, T Dehmel, R Hoepner, R Gold, ...
Annals of neurology 76 (6), 792-801, 2014
1002014
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations
I Ayzenberg, R Hoepner, I Kleiter
Therapeutics and clinical risk management 12, 261, 2016
832016
Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis
R Hoepner, S Faissner, A Salmen, R Gold, A Chan
Journal of central nervous system disease 6, JCNSD. S14049, 2014
802014
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study
I Ayzenberg, J Schöllhammer, R Hoepner, K Hellwig, M Ringelstein, ...
Journal of neurology 263 (3), 575-582, 2016
582016
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment
S Faissner, R Hoepner, C Lukas, A Chan, R Gold, G Ellrichmann
Therapeutic advances in neurological disorders 8 (5), 233-238, 2015
542015
Successful treatment of anti-Caspr2 syndrome by interleukin 6 receptor blockade through tocilizumab
C Krogias, R Hoepner, A Müller, C Schneider-Gold, A Schröder, R Gold
JAMA neurology 70 (8), 1056-1059, 2013
492013
Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study
A Miclea, VI Leussink, HP Hartung, R Gold, R Hoepner
Journal of neurology 263 (8), 1626-1632, 2016
452016
Ictal autoscopic phenomena and near death experiences: a study of five patients with ictal autoscopies
R Hoepner, K Labudda, TW May, M Schoendienst, FG Woermann, ...
Journal of neurology 260 (3), 742-749, 2013
422013
Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod
R Hoepner, J Havla, C Eienbröker, B Tackenberg, K Hellwig, I Meinl, ...
Multiple Sclerosis Journal 20 (13), 1714-1720, 2014
332014
Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy
R Hoepner, EM Kolb, S Dahlhaus, K Hellwig, O Adams, I Kleiter, ...
Multiple sclerosis journal 23 (6), 830-835, 2017
302017
Progressive multifocal leukoencephalopathy during fumarate monotherapy of psoriasis
R Hoepner, S Faissner, A Klasing, R Schneider, I Metz, B Bellenberg, ...
Neurology-Neuroimmunology Neuroinflammation 2 (3), e85, 2015
302015
Vitamin D supplementation differentially affects seasonal multiple sclerosis disease activity
A Miclea, M Miclea, M Pistor, A Hoepner, A Chan, R Hoepner
Brain and behavior 7 (8), 2017
292017
Informing patients about the impact of provocation methods increases the rate of psychogenic nonepileptic seizures during EEG recording
R Hoepner, K Labudda, M Schoendienst, TW May, CG Bien, C Brandt
Epilepsy & Behavior 28 (3), 457-459, 2013
282013
Distinguishing between patients with pure psychogenic nonepileptic seizures and those with comorbid epilepsy by means of clinical data
R Hoepner, K Labudda, TW May, M Schöndienst, CG Bien, C Brandt
Epilepsy & Behavior 35, 54-58, 2014
242014
Frequency and clinical characteristics of Multiple Sclerosis rebounds after withdrawal of Fingolimod
ME Evangelopoulos, A Miclea, L Schrewe, M Briner, A Salmen, ...
CNS neuroscience & therapeutics, 2018
222018
Prophylactic antiepileptic treatment reduces seizure frequency in natalizumab-associated progressive multifocal leukoencephalopathy
R Hoepner, S Dahlhaus, S Kollar, B Zurawski, A Chan, I Kleiter, R Gold, ...
Therapeutic advances in neurological disorders 7 (1), 3-6, 2014
132014
Unilateral autoscopic phenomena as a lateralizing sign in focal epilepsy
R Hoepner, K Labudda, M Hoppe, M Schoendienst, R Schulz, ...
Epilepsy & Behavior 23 (3), 360-363, 2012
122012
Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients
R Hoepner, J Ahlbrecht, S Faissner, R Schneider, S Dahlhaus, O Adams, ...
J Neurol Neurosurg Psychiatry 85 (10), 1177-1178, 2014
112014
Metabolic profiles by 1H-magnetic resonance spectroscopy in natalizumab-associated post-PML lesions of multiple sclerosis patients who survived progressive multifocal …
R Schneider, B Bellenberg, R Hoepner, EM Kolb, G Ellrichmann, ...
PloS one 12 (4), e0176415, 2017
92017
The system can't perform the operation now. Try again later.
Articles 1–20